Sigma-Aldrich has named Rich Keffer to the post of corporate vice president, general counsel, and secretary, effective Aug. 28. In his new role, Keffer will manage the firm’s legal services and corporate governance processes.
Keffer’s most recent general counsel experience was with D&K Healthcare, which was acquired by McKesson in 2005.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.